Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0OV3S
|
||||
Former ID |
DNC004044
|
||||
Drug Name |
4-[1-(4-hydroxyphenyl)-2-phenylpent-1-enyl]phenol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [526457] | ||
Structure |
Download2D MOL |
||||
Formula |
C23H22O2
|
||||
Canonical SMILES |
CCCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O)C3=CC=CC=C3
|
||||
InChI |
1S/C23H22O2/c1-2-6-22(17-7-4-3-5-8-17)23(18-9-13-20(24)14-10-18)19-11-15-21(25)16-12-19/h3-5,7-16,24-25H,2,6H2,1H3
|
||||
InChIKey |
UTLLHWVRVATSPI-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Estrogen receptor | Target Info | Inhibitor | [526457] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Signaling events mediated by HDAC Class II | |||||
Plasma membrane estrogen receptor signaling | |||||
LKB1 signaling events | |||||
Regulation of Telomerase | |||||
ATF-2 transcription factor network | |||||
AP-1 transcription factor network | |||||
FOXM1 transcription factor network | |||||
Validated nuclear estrogen receptor alpha network | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
FOXA1 transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.